跳至主導覽 跳至搜尋 跳過主要內容

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy

  • Luyi Han
  • , Tao Tan
  • , Tianyu Zhang
  • , Yuan Gao
  • , Xin Wang
  • , Valentina Longo
  • , Sofía Ventura-Díaz
  • , Anna D’angelo
  • , Yue Sun
  • , Jonas Teuwen
  • , Ritse Mann
  • Radboud University Nijmegen
  • Netherlands Cancer Institute
  • Catholic University of the Sacred Heart
  • Hospital Ramon y Cajal
  • IRCCS Roma
  • Macao Polytechnic University

研究成果: Article › 同儕審查

2 引文 斯高帕斯(Scopus)

摘要

Purpose: To develop a deep learning–based deformable registration method for dynamic contrast-enhanced (DCE) breast MRI that preserves tumor regions while maintaining global anatomic alignment during neoadjuvant chemotherapy (NAC) response assessment. Materials and Methods: This retrospective study included internal and external cohorts of patients with breast cancer who were undergoing NAC. The internal cohort comprised patients who underwent DCE MRI from 2017 to 2020, and the external cohort was derived from the I-SPY2 trial. A conditional pyramid registration network integrating unsupervised keypoint detection with a volume-preserving mechanism was developed. Registration performance was evaluated using the Dice similarity coefficient (DSC), average landmark error, and tumor volume difference. A local-global biomarker derived from registered images was evaluated for predicting pathologic complete response (pCR) using the area under the receiver operating characteristic curve (AUC) and accuracy. Paired t tests were used for statistical comparisons. Results: In 314 patients (all female; age, 50.6 years ± 12.0 [SD]) with 1630 scans in the internal cohort, the proposed method achieved a DSC of 0.95 ± 0.02, an average landmark error of 5.35 mm ± 3.46, and a tumor volume difference of 11.0% ± 10.7. In 100 patients (all female; age, 48.5 years ± 12.3) with 372 scans in the external cohort, the method achieved a DSC of 0.91 ± 0.09 and a tumor volume difference of 15.5% ± 13.8. Improvements in landmark distance and tumor preservation were statistically significant (P < .05) compared with most methods. For pCR prediction, incorporation of the proposed biomarker achieved an AUC of 0.81 ± 0.04 and an accuracy of 72.1% ± 5.0. Conclusion: The proposed framework improved anatomic alignment while preserving tumor volume in longitudinal DCE breast MRI during NAC response assessment and enabled a registration-based biomarker for predicting treatment response.

原文English
文章編號e250789
期刊Radiology: Artificial Intelligence
卷8
發行號4
DOIs
出版品狀態Published - 7月 2026

UN SDG

此研究成果有助於以下永續發展目標

  1. Good health and well being
    Good health and well being

指紋

深入研究「Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy」主題。共同形成了獨特的指紋。

引用此